There were 492 press releases posted in the last 24 hours and 185,299 in the last 365 days.

Telmisartan Market to Generate $4.25 Billion by 2027: Allied Market Research

Increase in healthcare expenditure, surge in awareness related to high blood pressure treatment options, and rise in hypertension among people worldwide drive the growth of the global telmisartan market. North America accounted for the highest share in 2019, and is estimated to maintain its lead position by 2027. Manufacturing activities of telmisartan tablets have been affected by lockdown measures implemented by governments.

/EIN News/ -- Portland, OR, March 18, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Telmisartan Market garnered $3.45 billion in 2019, and is projected to generate $4.25 billion by 2027, witnessing a CAGR of 3.4% from 2020 to 2027. The report provides detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, competitive scenario, and regional landscape.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/10658

Increase in healthcare expenditure, surge in awareness related to high blood pressure treatment options, and rise in hypertension among people worldwide drive the growth of the global telmisartan market. However, shortages in tablets of telmisartan restrain the market growth. Contrarily, untapped potential in developing regions is projected to present new opportunities in the coming years.

Covid-19 Scenario:

  • Manufacturing activities of telmisartan tablets have been affected by lockdown measures implemented by governments. In addition, there were restrictions on raw material procurement.
  • However, the distribution activities have been impacted by the Covid-19 pandemic up to a limited extent. Drug stores and retail pharmacies were open for limited hours of the day during the lockdown. The online deliveries were completely closed down.
  • During the post-lockdown, manufacturing activities would gain momentum, the online deliveries would begin, and drug stores and pharmacies would begin their distribution throughout the day. 

By indication, the hypertension segment accounted for the largest market share in 2019, contributing to nearly 90% of the total market share, and is expected to maintain its leadership status during the forecast period. However, the cardiovascular risk reduction segment is expected to witness the fastest CAGR of 4.3% from 2020 to 2027.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/10658

By distribution channel, the hospital pharmacies segment held the largest market share in 2019, accounting for more than half of the global telmisartan market, and will continue its dominant share in terms of revenue during the forecast period. However, the online pharmacies segment is estimated to portray the highest CAGR of 4.5% from 2020 to 2027.

By region, North America accounted for the highest share in 2019, contributing to more than one-third of the total market share, and is estimated to maintain its lead position by 2027. However, Asia-Pacific is expected to maintain the largest CAGR of 5.2% during the forecast period.

Leading players of the global telmisartan market analyzed in the research include Abbott Laboratories, Boehringer Ingelheim International GmbH, Aurobindo Pharma, Glaxosmithkline Plc (GSK), Cipla Inc., Sanofi, Mylan N.V., Teva Pharmaceutical Industries Ltd. (Actavis Generics), Sun Pharmaceutical Industries Limited, and Zydus Cadila.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.


Similar Reports:

Neutropenia Market - Global Opportunity Analysis and Industry Forecast, 2020–2027

Oral Antibiotics Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Surrogacy Market - Global Opportunity Analysis and Industry Forecast, 2019-2027

Pharmaceutical Drug Delivery Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Immunosuppressants Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Hybrid Operating Room Market - Global Opportunity Analysis and Industry Forecast, 2019–2027

Cell Therapy Market - Global Opportunity Analysis and Industry Forecast, 2019–2027


About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Primary Logo